on 30 Oct 2024
Last Applicant/ Owned by
OXCIA AB
Norrbackagatan 70 CSE-113 34 STOCKHOLM
SE
Serial Number
2176456 filed on 23rd Feb 2022
Correspondent Address
SUITE 1000, 55 METCALFE STREETP.O. BOX 2999, STATION DOttawa
ONTARIO
CA
K1P5Y6
Trademark usage description
pharmaceutical preparations for the treatment and prevention of cancer, inflammation, pulmonary fibrosis, sepsis, respiratory diseases, psoriasis and Read More11
11
11
2176456
Trademark
Action Taken | Status |
---|---|
Submitted for opposition 48 on 19th Jan 2024 | Agent Changed |
Submitted for opposition 22 on 19th Jul 2023 | Search Recorded |
Submitted for opposition 20 on 19th Jul 2023 | Examiner's First Report |
Submitted for opposition 223 on 19th Jul 2023 | Total Provisional Refusal |
Submitted for opposition 256 on 31st Jan 2023 | Notification of Possible Opposition Sent |
Submitted for opposition 257 on 31st Mar 2022 | Designation Notification - Madrid Protocol |
Submitted for opposition 1 on 30th Mar 2022 | Created |
Submitted for opposition 31 on 30th Mar 2022 | Formalized |
Submitted for opposition 30 on 23rd Feb 2022 | Filed |
Submitted for opposition 228 on 23rd Feb 2022 | International Registration |